SelectScience InterviewsGeneral Lab

Freezing technology behind conjugate vaccine development

23 Jun 2020
Freezing technology behind conjugate vaccine development

‘Everybody in the lab loves a new freezer – it’s cool’. Dr. Andrew Lees, founder, CEO and Scientific Director of Fina Biosolutions, explains how the installation of energy-efficient, reliable, and quickly recovering PHCbi freezers has been vital in enabling the delivery of Fina Biosolutions’s bioconjugation, protein and conjugate vaccine services. He's a magician, who decided to get into the world of science...

Other videos from SelectScience

Links